141 related articles for article (PubMed ID: 38001127)
1. Prognostic significance of high NPC2 expression in gastric cancer.
Yao Y; Ren J; Lu J; Sui Y; Gong J; Chen X
Sci Rep; 2023 Nov; 13(1):20710. PubMed ID: 38001127
[TBL] [Abstract][Full Text] [Related]
2. High expression of integrin-binding sialoprotein (IBSP) is associated with poor prognosis of osteosarcoma.
Ma Y; Chen B; Zhang B; Zhang C; Zhu Q; Wang X; Liu Z; Liu H
Aging (Albany NY); 2023 Nov; 16(1):28-42. PubMed ID: 38006395
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CARLo-5 upregulation associates with poor prognosis in patients suffering gastric cancer.
Liu JN; Shangguan YM
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):530-534. PubMed ID: 28239816
[TBL] [Abstract][Full Text] [Related]
4. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
[TBL] [Abstract][Full Text] [Related]
5. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
6. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Zhu C; Xiao D
Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
[TBL] [Abstract][Full Text] [Related]
7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.
Sun M; Jin FY; Xia R; Kong R; Li JH; Xu TP; Liu YW; Zhang EB; Liu XH; De W
BMC Cancer; 2014 May; 14():319. PubMed ID: 24884417
[TBL] [Abstract][Full Text] [Related]
9. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
10. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
11. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic ADAM28 induces gemcitabine resistance and predicts a poor prognosis in pancreatic cancer.
Wei L; Wen JY; Chen J; Ma XK; Wu DH; Chen ZH; Huang JL
World J Gastroenterol; 2019 Oct; 25(37):5590-5603. PubMed ID: 31602160
[TBL] [Abstract][Full Text] [Related]
14. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
Jin W; Han H; Liu D
Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
16. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer.
Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ
Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
18. MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.
Hunt BG; Wicker CA; Bourn JR; Lower EE; Takiar V; Waltz SE
Breast Cancer Res Treat; 2020 Jun; 181(3):529-540. PubMed ID: 32342233
[TBL] [Abstract][Full Text] [Related]
19. Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.
Zhou WH; Tang F; Xu J; Wu X; Feng ZY; Li HG; Lin DJ; Shao CK; Liu Q
BMC Cancer; 2011 Sep; 11():397. PubMed ID: 21933426
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA AP000695.2 as a Novel Prognostic Biomarker for Gastric Cancer.
Cheng Y; Yi X; Fu S; Cheng J; Li W; Xu H
Discov Med; 2023 Feb; 35(174):28-35. PubMed ID: 37024439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
